Christian Beaudry

Chief Operating and Scientific Officer

Mr. Beaudry is an executive and entrepreneur with more than twenty-five years of biopharmaceutical and scientific research experience and brings proven success in the development and commercialization of novel biological products. His diverse background includes expertise in cellular biology, biomedical technology, regulatory compliance, quality systems, business operations, research and development, and scientific research spanning the commercial and academic sectors.

His professional experience includes directing and managing biopharmaceutical research facilities as well as conducting new product development and research investigations. Mr. Beaudry is co-founder of Equus Innovations (Phoenix, AZ) and AlphaLogix (Phoenix, AZ) where he serves as Chief Operating and Scientific Officer and Member, Board of Managers. In this capacity, he is responsible for overall research and development of amniotic tissue allografts and technologies including RenoVō® and AlphaFlo®, next generation equine and canine biologics.

Prior to founding Equus Innovations and AlphaLogix, Mr. Beaudry served as Chief Scientific Officer at Amnio Technology where he was instrumental in developing and bringing to market the company’s human amniotic tissue product offerings. Additionally, he is listed as an inventor on 18 issued and pending patents, has co-authored 29 published scientific manuscripts and 2 book chapters, and has held
numerous research and operational appointments.

Mr. Beaudry earned a Master of Business Administration from the University of Phoenix, a Bachelor of Science in Medical Biology from the University of Quebec, is a certified Tissue Bank Specialist by the American Association of Tissue Banks, and is a Diplomat of the American Board of Regenerative Medicine.